Last reviewed · How we verify
NCT04013503: NATURE-HTN
National Tunisian Registry of Hypertension
trial in Hypertension in 25,000 participants. Completed in 15 May 2019.
15 May 2019
Quick facts
| Lead sponsor | Dacima Consulting |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25,000 |
| Start date | 15 April 2019 |
| Primary completion | 15 May 2019 |
| Estimated completion | 15 May 2019 |
| Sites | 1 location across Tunisia |
Conditions studied
- Hypertension — all drugs for Hypertension →
Sponsor
Dacima Consulting
Who can join
Adults 18 to 95, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Tunisian Society of Cardiology and Cardiovascular Surgery (STCCCV) proposes to coordinate a national, observational, cross-sectional and multicenter survey carried out during one month. The main objective of the survey is to describe the blood pressure and cardiovascular risk profile of the hypertensive patient in Tunisia. This survey will allow us to have a generalized and updated view of the tunisian hypertensive patient in order to optimize treatment and to know the degree of adherence of practitioners to international recommendations in the care of the hypertension in Tunisia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Design and Rationale of the National Observational Multicentric Tunisian Registry of Hypertension: Protocol for Evaluating Hypertensive Patient Care in Clinical Practice.
Abid L, Hammami R, Abdesselem S, Boudiche S, et al · · 2022 · PMID 36053572 · DOI 10.2196/21878
Verify or expand the search:
- PubMed search for NCT04013503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Dacima Consulting trials
Trials by the same sponsor.
- NCT07034274 — National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical · recruiting
- NCT06934499 — Tunisian Lung Cancer Study · recruiting
- NCT06825533 — The Prevalence of Prediabetes in Primary Care Medicine in Tunisia · not yet recruiting
- NCT06445036 — Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism · not yet recruiting
- NCT05991089 — Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04013503 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dacima Consulting
- Last refreshed: 8 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04013503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing